ERIS LIFESCIENCES
Back to Income Statement
|
ERIS LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹392 Cr | ₹3,822 Cr | ₹406 Cr | ₹355 Cr | ₹296 Cr |
What is the latest Consolidated Net Profit of ERIS LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹392 Cr |
| Mar2024 | ₹3,822 Cr |
| Mar2023 | ₹406 Cr |
| Mar2022 | ₹355 Cr |
| Mar2021 | ₹296 Cr |
How is Consolidated Net Profit of ERIS LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹392 Cr | -89.74 | |
| Mar2024 | ₹3,822 Cr | 841.01 | |
| Mar2023 | ₹406 Cr | 14.35 | |
| Mar2022 | ₹355 Cr | 19.78 | |
| Mar2021 | ₹296 Cr | - | |
Compare Consolidated Net Profit of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹19,835.3 Cr | 3.6% | -8% | 14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 3.6% |
-8% |
14.2% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses